| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 100 | 2023 | 3265 | 6.630 |
Why?
|
| Stroke | 133 | 2023 | 9981 | 6.070 |
Why?
|
| Matrix Metalloproteinase 9 | 49 | 2022 | 638 | 5.230 |
Why?
|
| Astrocytes | 32 | 2021 | 1270 | 4.810 |
Why?
|
| Blood-Brain Barrier | 56 | 2022 | 1017 | 4.560 |
Why?
|
| Neuroprotective Agents | 42 | 2020 | 941 | 4.330 |
Why?
|
| Endothelial Cells | 45 | 2022 | 3479 | 4.020 |
Why?
|
| Tissue Plasminogen Activator | 40 | 2018 | 1261 | 3.950 |
Why?
|
| Cerebral Hemorrhage | 48 | 2023 | 2647 | 3.430 |
Why?
|
| Ischemic Attack, Transient | 28 | 2022 | 935 | 3.410 |
Why?
|
| Infarction, Middle Cerebral Artery | 33 | 2022 | 475 | 3.390 |
Why?
|
| Brain | 122 | 2024 | 26385 | 3.260 |
Why?
|
| Oligodendroglia | 24 | 2023 | 517 | 3.230 |
Why?
|
| Neurons | 67 | 2020 | 9338 | 2.930 |
Why?
|
| Cell Communication | 18 | 2021 | 1621 | 2.680 |
Why?
|
| Brain Injuries | 34 | 2022 | 2025 | 2.570 |
Why?
|
| Neural Stem Cells | 18 | 2021 | 851 | 2.400 |
Why?
|
| Matrix Metalloproteinases | 16 | 2021 | 391 | 2.280 |
Why?
|
| Rats | 126 | 2023 | 24260 | 2.180 |
Why?
|
| Cerebrovascular Circulation | 47 | 2019 | 2731 | 2.120 |
Why?
|
| HMGB1 Protein | 8 | 2013 | 133 | 2.080 |
Why?
|
| Animals | 347 | 2024 | 168757 | 1.980 |
Why?
|
| Endothelium, Vascular | 24 | 2020 | 4456 | 1.930 |
Why?
|
| Brain Edema | 22 | 2022 | 617 | 1.900 |
Why?
|
| Recovery of Function | 30 | 2022 | 2925 | 1.880 |
Why?
|
| Cerebral Cortex | 49 | 2023 | 5708 | 1.860 |
Why?
|
| Disease Models, Animal | 93 | 2024 | 18029 | 1.790 |
Why?
|
| Rats, Sprague-Dawley | 67 | 2021 | 8301 | 1.770 |
Why?
|
| Neovascularization, Physiologic | 16 | 2021 | 1351 | 1.720 |
Why?
|
| Microglia | 18 | 2023 | 1266 | 1.720 |
Why?
|
| Intracranial Embolism | 16 | 2017 | 202 | 1.690 |
Why?
|
| Cerebrovascular Disorders | 9 | 2024 | 1504 | 1.620 |
Why?
|
| Circadian Clocks | 3 | 2024 | 171 | 1.610 |
Why?
|
| Neurogenesis | 14 | 2020 | 838 | 1.610 |
Why?
|
| Central Nervous System Diseases | 8 | 2021 | 518 | 1.550 |
Why?
|
| Thrombolytic Therapy | 17 | 2019 | 2161 | 1.500 |
Why?
|
| Oxidative Stress | 28 | 2019 | 3086 | 1.440 |
Why?
|
| Matrix Metalloproteinase 2 | 20 | 2017 | 472 | 1.440 |
Why?
|
| Arachidonate 15-Lipoxygenase | 11 | 2019 | 85 | 1.430 |
Why?
|
| Cells, Cultured | 68 | 2023 | 19229 | 1.400 |
Why?
|
| Arachidonate 12-Lipoxygenase | 10 | 2019 | 80 | 1.350 |
Why?
|
| Reperfusion | 9 | 2020 | 284 | 1.340 |
Why?
|
| Circadian Rhythm | 6 | 2024 | 2624 | 1.300 |
Why?
|
| Oxygen | 21 | 2020 | 4189 | 1.290 |
Why?
|
| Mice | 159 | 2024 | 81183 | 1.220 |
Why?
|
| Mice, Inbred C57BL | 78 | 2023 | 21827 | 1.190 |
Why?
|
| Brain Infarction | 12 | 2019 | 299 | 1.180 |
Why?
|
| Ischemic Postconditioning | 2 | 2018 | 25 | 1.170 |
Why?
|
| Signal Transduction | 46 | 2020 | 23403 | 1.160 |
Why?
|
| Mitochondria | 12 | 2021 | 3520 | 1.120 |
Why?
|
| Fibrinolytic Agents | 16 | 2019 | 2158 | 1.120 |
Why?
|
| Microvessels | 9 | 2019 | 544 | 1.120 |
Why?
|
| Neuroglia | 9 | 2022 | 927 | 1.100 |
Why?
|
| Cerebral Infarction | 18 | 2022 | 1011 | 1.100 |
Why?
|
| Stem Cells | 11 | 2022 | 3567 | 1.090 |
Why?
|
| Pericytes | 4 | 2022 | 292 | 1.080 |
Why?
|
| Peptide Hydrolases | 6 | 2018 | 634 | 1.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 12 | 2020 | 3508 | 1.070 |
Why?
|
| Cell Hypoxia | 14 | 2019 | 675 | 1.070 |
Why?
|
| Capillary Permeability | 6 | 2019 | 798 | 1.060 |
Why?
|
| Lipoxygenase Inhibitors | 6 | 2019 | 94 | 1.010 |
Why?
|
| Foramen Ovale, Patent | 8 | 2021 | 223 | 0.990 |
Why?
|
| Up-Regulation | 26 | 2018 | 4217 | 0.950 |
Why?
|
| Meninges | 4 | 2024 | 190 | 0.930 |
Why?
|
| Diabetes Mellitus, Experimental | 8 | 2019 | 1116 | 0.930 |
Why?
|
| Plasminogen Activators | 5 | 2007 | 209 | 0.920 |
Why?
|
| Oxygen Inhalation Therapy | 6 | 2013 | 367 | 0.920 |
Why?
|
| Cell Death | 22 | 2017 | 1706 | 0.920 |
Why?
|
| Inflammation Mediators | 7 | 2021 | 1889 | 0.910 |
Why?
|
| Extracellular Space | 6 | 2018 | 594 | 0.900 |
Why?
|
| Glucose | 15 | 2020 | 4397 | 0.900 |
Why?
|
| Annexin A2 | 8 | 2018 | 44 | 0.880 |
Why?
|
| Globins | 7 | 2016 | 415 | 0.850 |
Why?
|
| Receptor, trkB | 2 | 2013 | 125 | 0.840 |
Why?
|
| Neuregulin-1 | 4 | 2015 | 142 | 0.840 |
Why?
|
| Reperfusion Injury | 10 | 2020 | 1026 | 0.820 |
Why?
|
| Interleukin-1beta | 10 | 2018 | 972 | 0.820 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2004 | 1285 | 0.820 |
Why?
|
| A Kinase Anchor Proteins | 6 | 2021 | 51 | 0.800 |
Why?
|
| Minocycline | 3 | 2013 | 163 | 0.780 |
Why?
|
| Nerve Regeneration | 7 | 2020 | 788 | 0.760 |
Why?
|
| Culture Media, Conditioned | 9 | 2019 | 537 | 0.750 |
Why?
|
| Mice, Knockout | 42 | 2021 | 14557 | 0.720 |
Why?
|
| Warfarin | 9 | 2017 | 1496 | 0.720 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2021 | 565 | 0.720 |
Why?
|
| Multipotent Stem Cells | 1 | 2021 | 186 | 0.710 |
Why?
|
| Epidermal Growth Factor | 2 | 2019 | 708 | 0.710 |
Why?
|
| Macrophages | 9 | 2019 | 5655 | 0.700 |
Why?
|
| Nitric Oxide Synthase | 7 | 2016 | 916 | 0.700 |
Why?
|
| Enzyme Inhibitors | 25 | 2017 | 3798 | 0.700 |
Why?
|
| Endothelium | 3 | 2018 | 778 | 0.690 |
Why?
|
| Encephalitis | 5 | 2012 | 423 | 0.690 |
Why?
|
| Male | 198 | 2022 | 350118 | 0.670 |
Why?
|
| Dementia, Vascular | 4 | 2023 | 128 | 0.670 |
Why?
|
| Rats, Inbred SHR | 12 | 2016 | 195 | 0.660 |
Why?
|
| Brain-Derived Neurotrophic Factor | 6 | 2017 | 604 | 0.660 |
Why?
|
| Subarachnoid Hemorrhage | 8 | 2021 | 1018 | 0.650 |
Why?
|
| Caspases | 6 | 2011 | 928 | 0.640 |
Why?
|
| Antigens, CD | 4 | 2020 | 4026 | 0.640 |
Why?
|
| Lithium Chloride | 2 | 2008 | 87 | 0.630 |
Why?
|
| Isoxazoles | 2 | 2019 | 216 | 0.630 |
Why?
|
| PPAR alpha | 1 | 2019 | 197 | 0.620 |
Why?
|
| Blood Vessels | 5 | 2012 | 1125 | 0.620 |
Why?
|
| Hydrogels | 3 | 2019 | 724 | 0.620 |
Why?
|
| Central Nervous System | 6 | 2024 | 1357 | 0.600 |
Why?
|
| Alzheimer Disease | 7 | 2024 | 8037 | 0.600 |
Why?
|
| Nerve Tissue Proteins | 14 | 2020 | 4462 | 0.600 |
Why?
|
| Rats, Wistar | 22 | 2022 | 1901 | 0.590 |
Why?
|
| Hyperoxia | 6 | 2008 | 262 | 0.580 |
Why?
|
| Humans | 205 | 2024 | 744343 | 0.580 |
Why?
|
| Neurotransmitter Agents | 7 | 2000 | 647 | 0.580 |
Why?
|
| Caspase 3 | 5 | 2020 | 758 | 0.570 |
Why?
|
| Lipocalins | 2 | 2015 | 170 | 0.570 |
Why?
|
| Ischemia | 9 | 2022 | 1907 | 0.570 |
Why?
|
| Phenylalanine | 3 | 2004 | 365 | 0.560 |
Why?
|
| Cardiovascular System | 1 | 2024 | 832 | 0.560 |
Why?
|
| Hypothermia, Induced | 6 | 2017 | 752 | 0.560 |
Why?
|
| Hypoxia-Ischemia, Brain | 3 | 2015 | 333 | 0.560 |
Why?
|
| Bioengineering | 1 | 2017 | 99 | 0.550 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2016 | 514 | 0.550 |
Why?
|
| Angiotensin II | 1 | 2019 | 881 | 0.550 |
Why?
|
| Animals, Newborn | 13 | 2018 | 2726 | 0.540 |
Why?
|
| Cell Differentiation | 15 | 2023 | 11483 | 0.540 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 4 | 2021 | 143 | 0.530 |
Why?
|
| Intracranial Thrombosis | 5 | 2012 | 113 | 0.530 |
Why?
|
| Inflammation | 15 | 2022 | 10638 | 0.530 |
Why?
|
| Cell Membrane Permeability | 7 | 2020 | 590 | 0.530 |
Why?
|
| Free Radical Scavengers | 6 | 2018 | 216 | 0.520 |
Why?
|
| Extracellular Matrix | 7 | 2017 | 1741 | 0.520 |
Why?
|
| Thrombospondin 1 | 3 | 2017 | 250 | 0.520 |
Why?
|
| Cell Polarity | 1 | 2018 | 645 | 0.500 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2018 | 282 | 0.500 |
Why?
|
| Blood Coagulation Factors | 4 | 2014 | 355 | 0.490 |
Why?
|
| Organometallic Compounds | 4 | 2016 | 665 | 0.490 |
Why?
|
| Cell Survival | 18 | 2016 | 5882 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2015 | 2503 | 0.490 |
Why?
|
| Receptors, AMPA | 4 | 2008 | 331 | 0.490 |
Why?
|
| Glutamic Acid | 7 | 2009 | 1169 | 0.480 |
Why?
|
| Cell Movement | 8 | 2014 | 5217 | 0.480 |
Why?
|
| Nerve Degeneration | 3 | 2010 | 748 | 0.470 |
Why?
|
| Maze Learning | 9 | 2018 | 478 | 0.470 |
Why?
|
| Apoptosis | 15 | 2021 | 9727 | 0.470 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2012 | 452 | 0.470 |
Why?
|
| Gliosis | 3 | 2016 | 245 | 0.470 |
Why?
|
| Microcirculation | 9 | 2023 | 1286 | 0.460 |
Why?
|
| Recombinant Proteins | 16 | 2018 | 6622 | 0.460 |
Why?
|
| Immunohistochemistry | 25 | 2018 | 11366 | 0.460 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2019 | 4420 | 0.460 |
Why?
|
| Nerve Growth Factors | 5 | 2016 | 574 | 0.450 |
Why?
|
| Carbon Monoxide | 1 | 2016 | 531 | 0.450 |
Why?
|
| Proteomics | 5 | 2017 | 3638 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2023 | 11725 | 0.450 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 262 | 0.440 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 4 | 2016 | 265 | 0.440 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 11 | 2020 | 2737 | 0.430 |
Why?
|
| Dipeptides | 4 | 2013 | 409 | 0.430 |
Why?
|
| Collagenases | 5 | 2011 | 228 | 0.430 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2016 | 1375 | 0.430 |
Why?
|
| Anthracenes | 1 | 2012 | 84 | 0.430 |
Why?
|
| Magnetic Resonance Imaging | 35 | 2019 | 35421 | 0.420 |
Why?
|
| Blotting, Western | 13 | 2018 | 5179 | 0.420 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2013 | 162 | 0.420 |
Why?
|
| Quinoxalines | 3 | 2000 | 290 | 0.420 |
Why?
|
| Neurology | 2 | 2018 | 763 | 0.420 |
Why?
|
| Antipyrine | 4 | 2018 | 40 | 0.420 |
Why?
|
| Regeneration | 2 | 2021 | 1485 | 0.420 |
Why?
|
| Anticoagulants | 10 | 2023 | 4599 | 0.420 |
Why?
|
| Cell Proliferation | 17 | 2020 | 10481 | 0.420 |
Why?
|
| Metalloproteases | 1 | 2012 | 62 | 0.410 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2009 | 149 | 0.410 |
Why?
|
| Hippocampus | 14 | 2017 | 3675 | 0.410 |
Why?
|
| Hypoxia, Brain | 4 | 2015 | 133 | 0.400 |
Why?
|
| Neurodegenerative Diseases | 3 | 2023 | 1061 | 0.400 |
Why?
|
| Mice, Inbred Strains | 10 | 2014 | 1827 | 0.400 |
Why?
|
| Brain Concussion | 6 | 2022 | 1320 | 0.390 |
Why?
|
| Flavanones | 3 | 2010 | 71 | 0.390 |
Why?
|
| Stilbenes | 1 | 2012 | 156 | 0.390 |
Why?
|
| Glial Fibrillary Acidic Protein | 6 | 2021 | 528 | 0.390 |
Why?
|
| Biology | 2 | 2024 | 294 | 0.380 |
Why?
|
| Brain Chemistry | 3 | 2016 | 981 | 0.380 |
Why?
|
| L-Lactate Dehydrogenase | 9 | 2015 | 424 | 0.380 |
Why?
|
| Nitric Oxide Synthase Type I | 5 | 2016 | 170 | 0.380 |
Why?
|
| Intracranial Hemorrhages | 3 | 2012 | 855 | 0.380 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 1736 | 0.370 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1676 | 0.370 |
Why?
|
| Dipyridamole | 1 | 2010 | 145 | 0.370 |
Why?
|
| Isoflurane | 1 | 2013 | 380 | 0.370 |
Why?
|
| Disease Progression | 9 | 2022 | 13284 | 0.370 |
Why?
|
| Cell Cycle Proteins | 6 | 2021 | 3462 | 0.360 |
Why?
|
| Down-Regulation | 7 | 2016 | 3002 | 0.360 |
Why?
|
| Time Factors | 35 | 2022 | 40075 | 0.360 |
Why?
|
| Sphingosine | 3 | 2022 | 307 | 0.360 |
Why?
|
| Protease Inhibitors | 7 | 2013 | 791 | 0.360 |
Why?
|
| Cytotoxins | 1 | 2010 | 153 | 0.350 |
Why?
|
| Reactive Oxygen Species | 9 | 2021 | 2077 | 0.350 |
Why?
|
| Neuronal Plasticity | 8 | 2017 | 1422 | 0.350 |
Why?
|
| Edema | 3 | 2020 | 789 | 0.350 |
Why?
|
| Drug Delivery Systems | 3 | 2019 | 2219 | 0.350 |
Why?
|
| Acidosis, Lactic | 1 | 2011 | 142 | 0.350 |
Why?
|
| Dose-Response Relationship, Drug | 16 | 2015 | 10943 | 0.350 |
Why?
|
| Karyopherins | 1 | 2010 | 137 | 0.350 |
Why?
|
| Embryo, Mammalian | 5 | 2018 | 1701 | 0.350 |
Why?
|
| Research | 3 | 2017 | 1999 | 0.340 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2010 | 215 | 0.340 |
Why?
|
| Aging | 7 | 2024 | 8664 | 0.340 |
Why?
|
| Coagulants | 1 | 2009 | 49 | 0.340 |
Why?
|
| Cerebral Arteries | 4 | 2019 | 494 | 0.340 |
Why?
|
| Cell Line | 16 | 2019 | 15997 | 0.330 |
Why?
|
| Imidazoles | 6 | 2014 | 1206 | 0.320 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2010 | 261 | 0.320 |
Why?
|
| Hemoglobins | 5 | 2008 | 1534 | 0.320 |
Why?
|
| Acid-Base Imbalance | 1 | 2008 | 41 | 0.320 |
Why?
|
| Thrombophilia | 2 | 2021 | 305 | 0.320 |
Why?
|
| Fibroblast Growth Factors | 3 | 2018 | 879 | 0.310 |
Why?
|
| MAP Kinase Signaling System | 3 | 2012 | 1526 | 0.310 |
Why?
|
| Hyperbaric Oxygenation | 2 | 2009 | 163 | 0.310 |
Why?
|
| Antioxidants | 6 | 2011 | 1663 | 0.310 |
Why?
|
| Neovascularization, Pathologic | 2 | 2011 | 2635 | 0.310 |
Why?
|
| Nitric Oxide | 4 | 2013 | 2132 | 0.310 |
Why?
|
| Cortical Spreading Depression | 4 | 2015 | 276 | 0.310 |
Why?
|
| Acute Disease | 12 | 2018 | 7149 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 648 | 0.300 |
Why?
|
| Necrosis | 5 | 2020 | 1643 | 0.300 |
Why?
|
| Proteome | 3 | 2012 | 1799 | 0.300 |
Why?
|
| Heart Arrest | 2 | 2017 | 1470 | 0.300 |
Why?
|
| N-Methylaspartate | 4 | 1998 | 231 | 0.290 |
Why?
|
| Laser-Doppler Flowmetry | 6 | 2011 | 242 | 0.290 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2010 | 871 | 0.290 |
Why?
|
| Microdialysis | 8 | 2001 | 158 | 0.290 |
Why?
|
| Hematoma | 5 | 2014 | 758 | 0.290 |
Why?
|
| rho-Associated Kinases | 4 | 2020 | 279 | 0.290 |
Why?
|
| Physical Conditioning, Animal | 2 | 2021 | 362 | 0.290 |
Why?
|
| Phenotype | 7 | 2020 | 16365 | 0.290 |
Why?
|
| Radiation Injuries, Experimental | 3 | 1992 | 91 | 0.280 |
Why?
|
| Hemorrhage | 5 | 2022 | 3461 | 0.280 |
Why?
|
| Simvastatin | 2 | 2006 | 360 | 0.280 |
Why?
|
| Phagocytosis | 4 | 2023 | 1539 | 0.280 |
Why?
|
| Amides | 4 | 2017 | 459 | 0.280 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2009 | 675 | 0.280 |
Why?
|
| Histone Deacetylases | 3 | 2020 | 728 | 0.280 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2019 | 377 | 0.270 |
Why?
|
| Neuroimmunomodulation | 2 | 2009 | 157 | 0.270 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2001 | 1121 | 0.270 |
Why?
|
| Myelin Sheath | 6 | 2023 | 652 | 0.270 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 2 | 2019 | 271 | 0.260 |
Why?
|
| Liposomes | 2 | 2012 | 759 | 0.260 |
Why?
|
| Endoplasmic Reticulum | 4 | 2021 | 1144 | 0.260 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2008 | 895 | 0.260 |
Why?
|
| Blood Coagulation | 3 | 2014 | 1127 | 0.260 |
Why?
|
| Stem Cell Transplantation | 5 | 2020 | 1620 | 0.250 |
Why?
|
| Adherens Junctions | 2 | 2019 | 90 | 0.250 |
Why?
|
| Intracranial Arteriovenous Malformations | 3 | 1993 | 356 | 0.250 |
Why?
|
| Gelsolin | 3 | 2014 | 190 | 0.250 |
Why?
|
| Hydrogen Peroxide | 4 | 2021 | 731 | 0.250 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 2938 | 0.250 |
Why?
|
| Enzyme Induction | 4 | 2013 | 475 | 0.250 |
Why?
|
| Cell Culture Techniques | 5 | 2018 | 1678 | 0.250 |
Why?
|
| Protein C | 1 | 2004 | 138 | 0.240 |
Why?
|
| Image Interpretation, Computer-Assisted | 7 | 2018 | 3327 | 0.240 |
Why?
|
| Somatosensory Cortex | 4 | 2015 | 528 | 0.240 |
Why?
|
| beta-Alanine | 3 | 2014 | 74 | 0.240 |
Why?
|
| Body Water | 3 | 2008 | 343 | 0.240 |
Why?
|
| F2-Isoprostanes | 2 | 2018 | 35 | 0.240 |
Why?
|
| Behavior, Animal | 9 | 2020 | 1881 | 0.240 |
Why?
|
| Enzyme Activation | 10 | 2014 | 3701 | 0.240 |
Why?
|
| RNA, Messenger | 12 | 2022 | 13033 | 0.230 |
Why?
|
| Mice, Transgenic | 12 | 2024 | 9734 | 0.230 |
Why?
|
| Molecular Chaperones | 2 | 2009 | 742 | 0.230 |
Why?
|
| C-Reactive Protein | 4 | 2021 | 3778 | 0.230 |
Why?
|
| Amyloid beta-Peptides | 4 | 2023 | 3587 | 0.230 |
Why?
|
| Blood Proteins | 4 | 2012 | 1124 | 0.230 |
Why?
|
| Receptors, Lipoprotein | 1 | 2003 | 81 | 0.230 |
Why?
|
| Benzimidazoles | 3 | 2014 | 850 | 0.230 |
Why?
|
| Vinyl Compounds | 2 | 2014 | 20 | 0.230 |
Why?
|
| Brain Damage, Chronic | 3 | 2008 | 265 | 0.230 |
Why?
|
| Cerebral Ventricles | 1 | 2006 | 544 | 0.230 |
Why?
|
| Carotid Stenosis | 2 | 2023 | 854 | 0.220 |
Why?
|
| Infrared Rays | 2 | 2015 | 249 | 0.220 |
Why?
|
| Stress, Physiological | 2 | 2016 | 1403 | 0.220 |
Why?
|
| In Situ Nick-End Labeling | 7 | 2014 | 643 | 0.220 |
Why?
|
| Drug Administration Schedule | 7 | 2014 | 4933 | 0.220 |
Why?
|
| Rabbits | 15 | 1998 | 4894 | 0.220 |
Why?
|
| Blood Flow Velocity | 5 | 2008 | 1423 | 0.220 |
Why?
|
| Hypertension | 3 | 2018 | 8480 | 0.220 |
Why?
|
| Basal Ganglia | 4 | 2006 | 546 | 0.220 |
Why?
|
| Neuralgia | 1 | 2009 | 570 | 0.220 |
Why?
|
| Thiophenes | 3 | 2004 | 588 | 0.220 |
Why?
|
| Analysis of Variance | 10 | 2014 | 6365 | 0.210 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2019 | 2557 | 0.210 |
Why?
|
| Microelectrodes | 1 | 2023 | 303 | 0.210 |
Why?
|
| Glycogen Synthase Kinase 3 | 4 | 2014 | 430 | 0.210 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2013 | 957 | 0.210 |
Why?
|
| Cytoprotection | 5 | 2009 | 210 | 0.200 |
Why?
|
| Aquaporins | 1 | 2022 | 174 | 0.200 |
Why?
|
| Hemodynamics | 9 | 2012 | 4199 | 0.200 |
Why?
|
| HMGA1a Protein | 1 | 2022 | 64 | 0.200 |
Why?
|
| Cadherins | 2 | 2020 | 907 | 0.200 |
Why?
|
| Amino Acids | 3 | 1998 | 1736 | 0.200 |
Why?
|
| Neurotoxins | 2 | 1999 | 237 | 0.200 |
Why?
|
| Propylene Glycols | 2 | 2013 | 92 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 4554 | 0.200 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2015 | 707 | 0.200 |
Why?
|
| Butadienes | 3 | 2010 | 110 | 0.200 |
Why?
|
| Models, Cardiovascular | 3 | 2016 | 996 | 0.200 |
Why?
|
| Tight Junctions | 2 | 2008 | 311 | 0.200 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2022 | 262 | 0.200 |
Why?
|
| Gene Expression Regulation | 10 | 2015 | 12072 | 0.200 |
Why?
|
| Oligopeptides | 4 | 2014 | 1189 | 0.200 |
Why?
|
| Receptor, EphB2 | 1 | 2020 | 25 | 0.190 |
Why?
|
| Ephrin-B2 | 1 | 2020 | 39 | 0.190 |
Why?
|
| Spleen | 2 | 2022 | 2362 | 0.190 |
Why?
|
| Pyrrolidines | 2 | 2014 | 342 | 0.190 |
Why?
|
| Protons | 5 | 2017 | 1127 | 0.190 |
Why?
|
| Adult Stem Cells | 2 | 2021 | 216 | 0.190 |
Why?
|
| Chromones | 2 | 2012 | 154 | 0.190 |
Why?
|
| Models, Biological | 9 | 2018 | 9583 | 0.190 |
Why?
|
| Embolism, Paradoxical | 1 | 2021 | 58 | 0.190 |
Why?
|
| Extracellular Fluid | 2 | 2017 | 167 | 0.190 |
Why?
|
| Neutrophils | 6 | 2021 | 3719 | 0.190 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 1438 | 0.190 |
Why?
|
| RNA, Small Interfering | 7 | 2022 | 3505 | 0.190 |
Why?
|
| Spin Trapping | 1 | 2000 | 5 | 0.190 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 1504 | 0.190 |
Why?
|
| Basal Ganglia Hemorrhage | 1 | 2000 | 6 | 0.190 |
Why?
|
| Serum Amyloid P-Component | 2 | 2021 | 47 | 0.180 |
Why?
|
| Wound Healing | 2 | 2014 | 2785 | 0.180 |
Why?
|
| Treatment Outcome | 27 | 2023 | 63114 | 0.180 |
Why?
|
| Drug Therapy, Combination | 11 | 2020 | 6489 | 0.180 |
Why?
|
| Intercellular Adhesion Molecule-1 | 4 | 2015 | 1155 | 0.180 |
Why?
|
| Thromboembolism | 2 | 2013 | 986 | 0.180 |
Why?
|
| Erythropoietin | 1 | 2005 | 726 | 0.180 |
Why?
|
| Models, Neurological | 4 | 2016 | 1774 | 0.180 |
Why?
|
| Fibrinolysis | 3 | 2013 | 322 | 0.180 |
Why?
|
| Electrodes, Implanted | 2 | 2023 | 824 | 0.180 |
Why?
|
| Corpus Striatum | 5 | 2016 | 1221 | 0.180 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 822 | 0.180 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2019 | 3255 | 0.180 |
Why?
|
| Endothelium, Lymphatic | 1 | 2019 | 58 | 0.180 |
Why?
|
| Hemorrhagic Disorders | 2 | 2012 | 36 | 0.180 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2014 | 2109 | 0.180 |
Why?
|
| Actins | 3 | 2011 | 2121 | 0.180 |
Why?
|
| Evoked Potentials, Somatosensory | 3 | 2008 | 243 | 0.180 |
Why?
|
| Lymphatic Vessels | 1 | 2024 | 353 | 0.170 |
Why?
|
| Atrial Appendage | 1 | 2023 | 283 | 0.170 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2020 | 171 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2019 | 126 | 0.170 |
Why?
|
| Mass Spectrometry | 4 | 2021 | 2203 | 0.170 |
Why?
|
| Middle Cerebral Artery | 5 | 2018 | 264 | 0.170 |
Why?
|
| Motor Activity | 6 | 2019 | 2714 | 0.170 |
Why?
|
| Blood Volume | 5 | 2012 | 565 | 0.170 |
Why?
|
| Chemokines | 3 | 2016 | 970 | 0.170 |
Why?
|
| Heparitin Sulfate | 1 | 2020 | 225 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2019 | 118 | 0.170 |
Why?
|
| Cell Transdifferentiation | 1 | 2020 | 172 | 0.170 |
Why?
|
| Acetylglucosamine | 1 | 2020 | 191 | 0.170 |
Why?
|
| Regional Blood Flow | 5 | 2013 | 1525 | 0.170 |
Why?
|
| Cytokines | 6 | 2018 | 7322 | 0.170 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2038 | 0.170 |
Why?
|
| Glutaminase | 1 | 1998 | 35 | 0.170 |
Why?
|
| Chemokine CCL2 | 1 | 2021 | 617 | 0.170 |
Why?
|
| Cell Adhesion | 3 | 2014 | 3144 | 0.170 |
Why?
|
| Angiogenic Proteins | 1 | 2019 | 104 | 0.170 |
Why?
|
| Image Enhancement | 4 | 2016 | 2921 | 0.170 |
Why?
|
| Neural Crest | 1 | 2021 | 275 | 0.160 |
Why?
|
| Infusions, Intraventricular | 1 | 2018 | 36 | 0.160 |
Why?
|
| Evans Blue | 3 | 2022 | 45 | 0.160 |
Why?
|
| omega-Conotoxins | 1 | 1998 | 18 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 4 | 2014 | 7181 | 0.160 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 1338 | 0.160 |
Why?
|
| Pain | 3 | 2009 | 4986 | 0.160 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 5524 | 0.160 |
Why?
|
| Mammals | 1 | 2024 | 1143 | 0.160 |
Why?
|
| Oxygen Consumption | 4 | 2015 | 1869 | 0.160 |
Why?
|
| Tauopathies | 1 | 2022 | 307 | 0.160 |
Why?
|
| Naphthalenes | 1 | 2019 | 194 | 0.160 |
Why?
|
| Adrenomedullin | 2 | 2015 | 87 | 0.160 |
Why?
|
| Metalloendopeptidases | 2 | 2013 | 396 | 0.160 |
Why?
|
| Perfusion Imaging | 1 | 2019 | 195 | 0.160 |
Why?
|
| Dendrites | 1 | 2020 | 485 | 0.150 |
Why?
|
| Potassium | 3 | 2000 | 1336 | 0.150 |
Why?
|
| History, 20th Century | 4 | 2019 | 2740 | 0.150 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2018 | 133 | 0.150 |
Why?
|
| Dextromethorphan | 3 | 1991 | 38 | 0.150 |
Why?
|
| Dizocilpine Maleate | 3 | 1995 | 176 | 0.150 |
Why?
|
| Homeostasis | 3 | 2021 | 3340 | 0.150 |
Why?
|
| Leukocytes | 2 | 2019 | 2043 | 0.150 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2013 | 689 | 0.150 |
Why?
|
| Morpholines | 2 | 2012 | 571 | 0.150 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2017 | 1442 | 0.150 |
Why?
|
| History, 21st Century | 3 | 2019 | 1534 | 0.150 |
Why?
|
| Embolism | 1 | 2020 | 408 | 0.150 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2018 | 154 | 0.150 |
Why?
|
| Glycoproteins | 2 | 2017 | 2263 | 0.150 |
Why?
|
| Hyperglycemia | 3 | 2018 | 1373 | 0.150 |
Why?
|
| Membrane Potentials | 3 | 2020 | 1137 | 0.150 |
Why?
|
| Demyelinating Diseases | 2 | 2019 | 354 | 0.150 |
Why?
|
| Wnt Proteins | 1 | 2021 | 721 | 0.150 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2016 | 17 | 0.140 |
Why?
|
| Luminescent Measurements | 2 | 2011 | 405 | 0.140 |
Why?
|
| Permeability | 5 | 2019 | 738 | 0.140 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2018 | 664 | 0.140 |
Why?
|
| Pancreas | 1 | 2023 | 1686 | 0.140 |
Why?
|
| Membrane Potential, Mitochondrial | 5 | 2020 | 297 | 0.140 |
Why?
|
| tau Proteins | 2 | 2023 | 1868 | 0.140 |
Why?
|
| Flow Cytometry | 7 | 2020 | 5974 | 0.140 |
Why?
|
| Phosphorylation | 7 | 2020 | 8436 | 0.140 |
Why?
|
| Immunity | 1 | 2022 | 1012 | 0.140 |
Why?
|
| Cooperative Behavior | 3 | 2013 | 1504 | 0.140 |
Why?
|
| Bromodeoxyuridine | 1 | 2016 | 322 | 0.140 |
Why?
|
| Nitriles | 3 | 2010 | 956 | 0.140 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 668 | 0.140 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1226 | 0.140 |
Why?
|
| Treatment Failure | 2 | 2020 | 2618 | 0.140 |
Why?
|
| Compulsive Behavior | 1 | 2016 | 117 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 2 | 2018 | 1081 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2003 | 697 | 0.130 |
Why?
|
| Myosin Light Chains | 1 | 2015 | 121 | 0.130 |
Why?
|
| Magnesium Sulfate | 1 | 2015 | 68 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2016 | 103 | 0.130 |
Why?
|
| PPAR gamma | 1 | 2018 | 493 | 0.130 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2015 | 27 | 0.130 |
Why?
|
| Cell Membrane | 4 | 2014 | 3748 | 0.130 |
Why?
|
| Single-Blind Method | 2 | 2021 | 1590 | 0.130 |
Why?
|
| Fibrinolysin | 4 | 2013 | 131 | 0.130 |
Why?
|
| Genetic Markers | 1 | 2022 | 2634 | 0.130 |
Why?
|
| Female | 55 | 2022 | 380194 | 0.130 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 1152 | 0.130 |
Why?
|
| Biomedical Research | 4 | 2019 | 3309 | 0.130 |
Why?
|
| Injections, Intravenous | 4 | 2014 | 1420 | 0.130 |
Why?
|
| Sinus Thrombosis, Intracranial | 2 | 2013 | 103 | 0.130 |
Why?
|
| Apoptosis Inducing Factor | 2 | 2016 | 55 | 0.130 |
Why?
|
| Gadolinium DTPA | 4 | 2008 | 836 | 0.130 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2022 | 859 | 0.120 |
Why?
|
| STAT Transcription Factors | 1 | 2015 | 182 | 0.120 |
Why?
|
| Spin Labels | 2 | 2018 | 332 | 0.120 |
Why?
|
| International Cooperation | 2 | 2019 | 1420 | 0.120 |
Why?
|
| Hypercapnia | 2 | 2008 | 260 | 0.120 |
Why?
|
| Neutrophil Infiltration | 3 | 2016 | 390 | 0.120 |
Why?
|
| Arm | 2 | 2012 | 589 | 0.120 |
Why?
|
| Water | 3 | 2011 | 1395 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 996 | 0.120 |
Why?
|
| Nervous System Diseases | 4 | 2020 | 1622 | 0.120 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 9438 | 0.120 |
Why?
|
| Pyridines | 4 | 2011 | 2825 | 0.120 |
Why?
|
| Laminin | 2 | 2009 | 419 | 0.120 |
Why?
|
| RNA Interference | 4 | 2014 | 2889 | 0.120 |
Why?
|
| Cell Count | 6 | 2011 | 1856 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 625 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 789 | 0.120 |
Why?
|
| Adrenoleukodystrophy | 1 | 2015 | 123 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2020 | 3068 | 0.120 |
Why?
|
| Isoquinolines | 1 | 2015 | 367 | 0.110 |
Why?
|
| NF-kappa B | 3 | 2022 | 2499 | 0.110 |
Why?
|
| Echo-Planar Imaging | 3 | 2018 | 659 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2020 | 1640 | 0.110 |
Why?
|
| Reticulocytes | 1 | 2014 | 290 | 0.110 |
Why?
|
| Membrane Proteins | 4 | 2009 | 7880 | 0.110 |
Why?
|
| Review Literature as Topic | 1 | 2015 | 336 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2019 | 8949 | 0.110 |
Why?
|
| Myocardium | 3 | 2018 | 4776 | 0.110 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 399 | 0.110 |
Why?
|
| Mitochondrial Diseases | 2 | 2014 | 320 | 0.110 |
Why?
|
| Iopamidol | 1 | 2013 | 191 | 0.110 |
Why?
|
| Contrast Media | 6 | 2013 | 5300 | 0.110 |
Why?
|
| Calcium Channel Blockers | 2 | 1998 | 690 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 1157 | 0.110 |
Why?
|
| Semaphorin-3A | 1 | 2012 | 39 | 0.110 |
Why?
|
| Neural Inhibition | 2 | 2011 | 602 | 0.110 |
Why?
|
| Calcium | 3 | 2023 | 5756 | 0.110 |
Why?
|
| Gangliosides | 2 | 2011 | 137 | 0.110 |
Why?
|
| Aged | 29 | 2023 | 163280 | 0.110 |
Why?
|
| Heart | 3 | 2024 | 4467 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.110 |
Why?
|
| Radiosurgery | 2 | 1993 | 1329 | 0.110 |
Why?
|
| Head Injuries, Closed | 2 | 2010 | 136 | 0.110 |
Why?
|
| Structure-Activity Relationship | 2 | 2015 | 3129 | 0.110 |
Why?
|
| Fibrinogen | 2 | 2013 | 894 | 0.110 |
Why?
|
| Benzamides | 1 | 1998 | 1379 | 0.110 |
Why?
|
| Collagen | 1 | 2021 | 2689 | 0.110 |
Why?
|
| Thrombectomy | 1 | 2017 | 680 | 0.110 |
Why?
|
| Molecular Probe Techniques | 1 | 2013 | 119 | 0.110 |
Why?
|
| Lipopolysaccharides | 2 | 2020 | 2216 | 0.100 |
Why?
|
| Brain Mapping | 4 | 2013 | 6669 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 560 | 0.100 |
Why?
|
| Chemotactic Factors | 1 | 2012 | 199 | 0.100 |
Why?
|
| Antithrombin Proteins | 1 | 2011 | 9 | 0.100 |
Why?
|
| Ischemic Preconditioning | 1 | 2012 | 92 | 0.100 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 168 | 0.100 |
Why?
|
| Myofibrils | 1 | 2012 | 146 | 0.100 |
Why?
|
| Cognition | 4 | 2023 | 6770 | 0.100 |
Why?
|
| Transcription, Genetic | 3 | 2022 | 7722 | 0.100 |
Why?
|
| Albumins | 2 | 2022 | 569 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 10180 | 0.100 |
Why?
|
| Endothelin-1 | 1 | 2013 | 314 | 0.100 |
Why?
|
| Functional Laterality | 3 | 2012 | 2290 | 0.100 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2013 | 311 | 0.100 |
Why?
|
| Immunochemistry | 1 | 2011 | 124 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2012 | 138 | 0.100 |
Why?
|
| Iron | 2 | 2015 | 1774 | 0.100 |
Why?
|
| Free Radicals | 2 | 2003 | 237 | 0.100 |
Why?
|
| Factor VII | 1 | 2011 | 139 | 0.100 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 281 | 0.100 |
Why?
|
| Antifibrinolytic Agents | 1 | 2013 | 254 | 0.100 |
Why?
|
| Placenta | 1 | 2020 | 1698 | 0.100 |
Why?
|
| Neurologic Examination | 3 | 2017 | 930 | 0.100 |
Why?
|
| Interleukins | 1 | 2016 | 791 | 0.100 |
Why?
|
| Corpus Callosum | 3 | 2024 | 737 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2011 | 3870 | 0.100 |
Why?
|
| Administration, Oral | 4 | 2015 | 3913 | 0.100 |
Why?
|
| Vibrissae | 1 | 2011 | 125 | 0.100 |
Why?
|
| Perfusion | 3 | 2012 | 1360 | 0.100 |
Why?
|
| Exosomes | 1 | 2015 | 417 | 0.100 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2013 | 426 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2013 | 1801 | 0.090 |
Why?
|
| Vascular Resistance | 1 | 1993 | 936 | 0.090 |
Why?
|
| Databases, Protein | 1 | 2012 | 383 | 0.090 |
Why?
|
| Middle Aged | 31 | 2022 | 213383 | 0.090 |
Why?
|
| Helium | 1 | 1991 | 123 | 0.090 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1996 | 719 | 0.090 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2013 | 197 | 0.090 |
Why?
|
| Antithrombins | 1 | 2013 | 304 | 0.090 |
Why?
|
| Serum Albumin, Bovine | 1 | 2011 | 324 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 238 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 2 | 2013 | 2657 | 0.090 |
Why?
|
| Lectins | 1 | 2013 | 513 | 0.090 |
Why?
|
| Aspirin | 2 | 2020 | 3282 | 0.090 |
Why?
|
| Immunoblotting | 2 | 2011 | 1682 | 0.090 |
Why?
|
| Lipoxygenase | 1 | 2010 | 74 | 0.090 |
Why?
|
| Proteoglycans | 2 | 2011 | 835 | 0.090 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 158 | 0.090 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2023 | 1121 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 1 | 2016 | 1005 | 0.090 |
Why?
|
| Indoles | 4 | 2014 | 1839 | 0.090 |
Why?
|
| Radio Waves | 1 | 2011 | 251 | 0.090 |
Why?
|
| Apolipoproteins | 1 | 2012 | 317 | 0.090 |
Why?
|
| Injections, Intraventricular | 3 | 2020 | 230 | 0.090 |
Why?
|
| Citrates | 1 | 2009 | 131 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 2 | 2014 | 2007 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2019 | 2455 | 0.090 |
Why?
|
| Coloring Agents | 4 | 2011 | 566 | 0.090 |
Why?
|
| Aged, 80 and over | 15 | 2022 | 57776 | 0.090 |
Why?
|
| Injections | 2 | 2011 | 840 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4751 | 0.080 |
Why?
|
| Vascular Diseases | 2 | 2018 | 1161 | 0.080 |
Why?
|
| Pyrazines | 1 | 2015 | 1230 | 0.080 |
Why?
|
| Predictive Value of Tests | 6 | 2019 | 15076 | 0.080 |
Why?
|
| Prognosis | 9 | 2020 | 29063 | 0.080 |
Why?
|
| Catechin | 1 | 2009 | 66 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2010 | 546 | 0.080 |
Why?
|
| Heme | 1 | 2011 | 307 | 0.080 |
Why?
|
| Neurosciences | 1 | 2013 | 348 | 0.080 |
Why?
|
| Chromans | 1 | 2008 | 122 | 0.080 |
Why?
|
| ROC Curve | 2 | 2017 | 3527 | 0.080 |
Why?
|
| Capillaries | 3 | 2019 | 773 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 2866 | 0.080 |
Why?
|
| Maleimides | 1 | 2008 | 112 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2019 | 4286 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 2013 | 570 | 0.080 |
Why?
|
| Malondialdehyde | 1 | 2008 | 105 | 0.080 |
Why?
|
| Microbial Collagenase | 1 | 2008 | 122 | 0.080 |
Why?
|
| Models, Animal | 2 | 2014 | 2171 | 0.080 |
Why?
|
| Evidence-Based Medicine | 3 | 2016 | 3610 | 0.080 |
Why?
|
| Deoxyglucose | 1 | 2008 | 337 | 0.080 |
Why?
|
| Pentetic Acid | 3 | 1994 | 213 | 0.080 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2013 | 835 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3474 | 0.080 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2008 | 91 | 0.080 |
Why?
|
| Protein Binding | 4 | 2018 | 9386 | 0.080 |
Why?
|
| Cell Separation | 1 | 2014 | 1751 | 0.080 |
Why?
|
| Movement Disorders | 2 | 2008 | 445 | 0.080 |
Why?
|
| Spinal Nerves | 1 | 2008 | 86 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 2916 | 0.080 |
Why?
|
| Microscopy, Confocal | 3 | 2015 | 1970 | 0.080 |
Why?
|
| Blood Coagulation Disorders | 1 | 2011 | 337 | 0.080 |
Why?
|
| Antigens | 2 | 2011 | 1466 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2010 | 595 | 0.080 |
Why?
|
| Seizures | 2 | 2012 | 2859 | 0.080 |
Why?
|
| Collagen Type IV | 1 | 2008 | 140 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1790 | 0.080 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2007 | 135 | 0.080 |
Why?
|
| Receptors, Immunologic | 2 | 2010 | 1423 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3920 | 0.070 |
Why?
|
| PC12 Cells | 2 | 2015 | 330 | 0.070 |
Why?
|
| Transfection | 4 | 2021 | 5892 | 0.070 |
Why?
|
| Forelimb | 2 | 2008 | 122 | 0.070 |
Why?
|
| Doxycycline | 1 | 2009 | 326 | 0.070 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 459 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2007 | 15540 | 0.070 |
Why?
|
| Fibrosis | 1 | 2014 | 2029 | 0.070 |
Why?
|
| Algorithms | 6 | 2016 | 13881 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 964 | 0.070 |
Why?
|
| Diffusion | 4 | 1997 | 833 | 0.070 |
Why?
|
| Health Priorities | 1 | 2010 | 380 | 0.070 |
Why?
|
| Causality | 1 | 2013 | 1275 | 0.070 |
Why?
|
| International Normalized Ratio | 1 | 2008 | 367 | 0.070 |
Why?
|
| National Health Programs | 1 | 2010 | 445 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 19905 | 0.070 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2014 | 232 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1157 | 0.070 |
Why?
|
| Blood Gas Analysis | 2 | 2012 | 383 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2011 | 818 | 0.070 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2018 | 379 | 0.070 |
Why?
|
| Time | 1 | 2008 | 542 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1632 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2006 | 99 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2013 | 1359 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 1655 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 2513 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2022 | 53288 | 0.070 |
Why?
|
| Retinal Ganglion Cells | 1 | 2011 | 770 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2915 | 0.070 |
Why?
|
| Case-Control Studies | 6 | 2015 | 21746 | 0.070 |
Why?
|
| Monocytes | 1 | 2015 | 2596 | 0.070 |
Why?
|
| Vasoconstriction | 2 | 2008 | 597 | 0.070 |
Why?
|
| Synaptophysin | 2 | 2017 | 141 | 0.070 |
Why?
|
| Intraocular Pressure | 1 | 2011 | 1270 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2715 | 0.070 |
Why?
|
| Anxiety | 2 | 2017 | 4297 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3647 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2016 | 5853 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3768 | 0.060 |
Why?
|
| Propidium | 3 | 2011 | 41 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 7913 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2009 | 1341 | 0.060 |
Why?
|
| Hydrogen | 1 | 2005 | 164 | 0.060 |
Why?
|
| Blood Pressure | 3 | 2001 | 8554 | 0.060 |
Why?
|
| Anoikis | 1 | 2004 | 49 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2011 | 20129 | 0.060 |
Why?
|
| Nitroprusside | 2 | 2009 | 275 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5034 | 0.060 |
Why?
|
| Comorbidity | 2 | 2017 | 10388 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2005 | 190 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 840 | 0.060 |
Why?
|
| Brefeldin A | 1 | 2004 | 72 | 0.060 |
Why?
|
| Recurrence | 3 | 2020 | 8340 | 0.060 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2004 | 34 | 0.060 |
Why?
|
| Rupture | 1 | 2006 | 433 | 0.060 |
Why?
|
| ras-GRF1 | 1 | 2004 | 26 | 0.060 |
Why?
|
| Intracranial Aneurysm | 1 | 2014 | 1197 | 0.060 |
Why?
|
| Thapsigargin | 1 | 2004 | 104 | 0.060 |
Why?
|
| Protein Transport | 1 | 2010 | 1988 | 0.060 |
Why?
|
| Tetrazolium Salts | 3 | 2014 | 96 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 2305 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2004 | 192 | 0.060 |
Why?
|
| Receptor, PAR-1 | 1 | 2004 | 113 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2020 | 546 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1213 | 0.060 |
Why?
|
| Computer Simulation | 5 | 2011 | 6196 | 0.060 |
Why?
|
| Flavonoids | 2 | 2009 | 443 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 1637 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2006 | 1730 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 4 | 2014 | 2699 | 0.060 |
Why?
|
| Radiation Injuries | 1 | 1991 | 1180 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 1992 | 1928 | 0.060 |
Why?
|
| Ion Channels | 1 | 2008 | 1056 | 0.060 |
Why?
|
| Risk Factors | 8 | 2022 | 72290 | 0.060 |
Why?
|
| Neurogenic Inflammation | 1 | 2002 | 33 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2021 | 2187 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5097 | 0.050 |
Why?
|
| Angiopoietin-1 | 2 | 2017 | 114 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2024 | 253 | 0.050 |
Why?
|
| Fatty Acid Desaturases | 1 | 2002 | 102 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2003 | 821 | 0.050 |
Why?
|
| Health Services Research | 1 | 2010 | 1836 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2006 | 729 | 0.050 |
Why?
|
| Protein Denaturation | 1 | 2002 | 237 | 0.050 |
Why?
|
| Pregnancy | 5 | 2020 | 29144 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2002 | 188 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 9648 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2002 | 195 | 0.050 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2005 | 903 | 0.050 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2002 | 67 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2861 | 0.050 |
Why?
|
| Memory | 2 | 2011 | 2174 | 0.050 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2002 | 171 | 0.050 |
Why?
|
| Cell Line, Tumor | 5 | 2015 | 16689 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2011 | 1792 | 0.050 |
Why?
|
| Glaucoma | 1 | 2011 | 1159 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2282 | 0.050 |
Why?
|
| Hydralazine | 1 | 2001 | 38 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2001 | 153 | 0.050 |
Why?
|
| Hypothermia | 1 | 2003 | 189 | 0.050 |
Why?
|
| Respiratory Burst | 1 | 2021 | 114 | 0.050 |
Why?
|
| Lasers | 1 | 2006 | 952 | 0.050 |
Why?
|
| Neostigmine | 1 | 2021 | 69 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2013 | 3336 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2021 | 76 | 0.050 |
Why?
|
| Taurine | 2 | 1998 | 94 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2005 | 534 | 0.050 |
Why?
|
| Adult | 18 | 2021 | 214055 | 0.050 |
Why?
|
| Glutathione Reductase | 1 | 2020 | 25 | 0.050 |
Why?
|
| Ferrosoferric Oxide | 1 | 2002 | 360 | 0.050 |
Why?
|
| Partial Pressure | 2 | 2011 | 254 | 0.050 |
Why?
|
| Endostatins | 1 | 2021 | 174 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2010 | 2969 | 0.050 |
Why?
|
| Migraine Disorders | 1 | 2013 | 1620 | 0.050 |
Why?
|
| Oxides | 1 | 2002 | 405 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 480 | 0.050 |
Why?
|
| Secondary Prevention | 2 | 2020 | 1530 | 0.050 |
Why?
|
| Kinetics | 2 | 2002 | 6473 | 0.050 |
Why?
|
| Calcium Channels, P-Type | 1 | 2000 | 9 | 0.050 |
Why?
|
| Cerebrospinal Fluid | 2 | 2021 | 534 | 0.050 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2000 | 68 | 0.050 |
Why?
|
| Antibodies | 1 | 2008 | 2460 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 489 | 0.050 |
Why?
|
| Cyclic N-Oxides | 1 | 2000 | 78 | 0.050 |
Why?
|
| Rats, Inbred WKY | 1 | 2000 | 158 | 0.050 |
Why?
|
| Electrophysiology | 3 | 2008 | 1308 | 0.050 |
Why?
|
| Carotid Artery, External | 1 | 1999 | 38 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2011 | 2508 | 0.040 |
Why?
|
| Republic of Korea | 1 | 2022 | 539 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2011 | 1479 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 2000 | 129 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 2278 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2018 | 2088 | 0.040 |
Why?
|
| Hemiplegia | 1 | 2000 | 135 | 0.040 |
Why?
|
| Cognition Disorders | 2 | 2013 | 4043 | 0.040 |
Why?
|
| Peptides | 2 | 2005 | 4409 | 0.040 |
Why?
|
| Septal Occluder Device | 1 | 2020 | 128 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2011 | 2972 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2002 | 381 | 0.040 |
Why?
|
| Synapses | 2 | 2000 | 1728 | 0.040 |
Why?
|
| White Muscle Disease | 1 | 2019 | 5 | 0.040 |
Why?
|
| Patient Selection | 2 | 2009 | 4215 | 0.040 |
Why?
|
| Osteopontin | 1 | 2021 | 296 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3752 | 0.040 |
Why?
|
| Dentition, Permanent | 1 | 1999 | 21 | 0.040 |
Why?
|
| Rats, Long-Evans | 2 | 2011 | 387 | 0.040 |
Why?
|
| Carotid Artery Injuries | 1 | 1999 | 96 | 0.040 |
Why?
|
| Pit and Fissure Sealants | 1 | 1999 | 27 | 0.040 |
Why?
|
| L-Selectin | 1 | 1999 | 213 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2005 | 1572 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2020 | 1990 | 0.040 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1999 | 202 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2019 | 90 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2019 | 2504 | 0.040 |
Why?
|
| ras Proteins | 1 | 2004 | 1060 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1227 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2001 | 640 | 0.040 |
Why?
|
| Lymphangiogenesis | 1 | 2019 | 172 | 0.040 |
Why?
|
| Species Specificity | 2 | 2016 | 2478 | 0.040 |
Why?
|
| Ethanolamines | 1 | 1998 | 158 | 0.040 |
Why?
|
| Hyperkinesis | 1 | 2018 | 89 | 0.040 |
Why?
|
| Sodium, Dietary | 1 | 2002 | 418 | 0.040 |
Why?
|
| Presynaptic Terminals | 1 | 2000 | 302 | 0.040 |
Why?
|
| Piperazines | 1 | 2008 | 2488 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2020 | 404 | 0.040 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2018 | 97 | 0.040 |
Why?
|
| Fluorescent Dyes | 3 | 2015 | 1917 | 0.040 |
Why?
|
| Insulin | 1 | 2012 | 6580 | 0.040 |
Why?
|
| Homocysteine | 1 | 2021 | 647 | 0.040 |
Why?
|
| Bradykinin | 2 | 2013 | 214 | 0.040 |
Why?
|
| Gelatin | 1 | 2019 | 225 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2020 | 597 | 0.040 |
Why?
|
| Ceruloplasmin | 1 | 2017 | 56 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2019 | 277 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 4149 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 1998 | 862 | 0.040 |
Why?
|
| Acrylamides | 1 | 2019 | 255 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 2 | 1991 | 1144 | 0.040 |
Why?
|
| Arteries | 1 | 2002 | 1119 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2022 | 495 | 0.040 |
Why?
|
| Random Allocation | 1 | 2021 | 2429 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2018 | 249 | 0.040 |
Why?
|
| Solubility | 1 | 1998 | 1085 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2017 | 185 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2019 | 720 | 0.040 |
Why?
|
| Glutathione | 2 | 2009 | 589 | 0.040 |
Why?
|
| Hydroxamic Acids | 1 | 1999 | 494 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2017 | 424 | 0.040 |
Why?
|
| Alanine | 1 | 1998 | 572 | 0.030 |
Why?
|
| Young Adult | 7 | 2020 | 56430 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2001 | 1276 | 0.030 |
Why?
|
| Haptoglobins | 1 | 2017 | 165 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2018 | 292 | 0.030 |
Why?
|
| Biological Transport | 1 | 2021 | 2118 | 0.030 |
Why?
|
| Graft Survival | 1 | 2006 | 3737 | 0.030 |
Why?
|
| Radiography | 2 | 2001 | 7023 | 0.030 |
Why?
|
| China | 2 | 2019 | 2248 | 0.030 |
Why?
|
| Tyrphostins | 1 | 2015 | 67 | 0.030 |
Why?
|
| Hand Strength | 2 | 2010 | 448 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 14722 | 0.030 |
Why?
|
| Hydrocephalus | 2 | 2013 | 748 | 0.030 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2015 | 4 | 0.030 |
Why?
|
| Electric Stimulation | 4 | 2008 | 1767 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2002 | 852 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5751 | 0.030 |
Why?
|
| Aminooxyacetic Acid | 1 | 2015 | 7 | 0.030 |
Why?
|
| Lentivirus | 1 | 2018 | 501 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2005 | 1563 | 0.030 |
Why?
|
| Glycine | 1 | 1998 | 671 | 0.030 |
Why?
|
| Cell Division | 1 | 2003 | 4568 | 0.030 |
Why?
|
| Neck | 1 | 2019 | 697 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2001 | 2234 | 0.030 |
Why?
|
| Leg | 1 | 2000 | 1116 | 0.030 |
Why?
|
| Adenosine Triphosphate | 2 | 2014 | 2025 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2021 | 2375 | 0.030 |
Why?
|
| Dental Caries | 1 | 1999 | 415 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2010 | 7729 | 0.030 |
Why?
|
| Arachnoid | 1 | 2014 | 48 | 0.030 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2014 | 56 | 0.030 |
Why?
|
| Serine | 1 | 1998 | 826 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2008 | 2751 | 0.030 |
Why?
|
| Body Temperature | 1 | 1998 | 777 | 0.030 |
Why?
|
| Benzothiazoles | 1 | 2015 | 248 | 0.030 |
Why?
|
| Mutation | 5 | 2017 | 29786 | 0.030 |
Why?
|
| Medical Informatics Computing | 1 | 1994 | 25 | 0.030 |
Why?
|
| Registries | 1 | 2010 | 8089 | 0.030 |
Why?
|
| Sex Factors | 2 | 2019 | 10397 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1997 | 449 | 0.030 |
Why?
|
| Thiazoles | 2 | 2014 | 1483 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2014 | 70 | 0.030 |
Why?
|
| Half-Life | 1 | 2015 | 661 | 0.030 |
Why?
|
| Antimutagenic Agents | 1 | 2013 | 7 | 0.030 |
Why?
|
| Hydrogen Sulfide | 1 | 2015 | 137 | 0.030 |
Why?
|
| Arthritis | 1 | 1999 | 659 | 0.030 |
Why?
|
| Mice, Nude | 3 | 2006 | 3689 | 0.030 |
Why?
|
| Arterioles | 1 | 2014 | 254 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2022 | 40561 | 0.030 |
Why?
|
| Reaction Time | 1 | 2000 | 2097 | 0.030 |
Why?
|
| Pseudopodia | 1 | 2014 | 172 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 1995 | 635 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 1996 | 525 | 0.030 |
Why?
|
| Matrix Metalloproteinases, Secreted | 1 | 2013 | 14 | 0.030 |
Why?
|
| Reference Values | 3 | 2000 | 4982 | 0.030 |
Why?
|
| Biopsy | 2 | 2019 | 6756 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 4838 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2001 | 1071 | 0.030 |
Why?
|
| Fatty Acids | 2 | 2015 | 1809 | 0.030 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2012 | 16 | 0.030 |
Why?
|
| Cobalt | 1 | 2013 | 158 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1999 | 1783 | 0.030 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 237 | 0.030 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2002 | 1344 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 1996 | 1866 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 1726 | 0.030 |
Why?
|
| Gene Expression | 2 | 2016 | 7799 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 13815 | 0.030 |
Why?
|
| Guidelines as Topic | 2 | 2010 | 1405 | 0.030 |
Why?
|
| Streptozocin | 1 | 2013 | 196 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2003 | 4161 | 0.030 |
Why?
|
| Benzofurans | 1 | 2013 | 140 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2440 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2019 | 1178 | 0.030 |
Why?
|
| S100 Proteins | 1 | 2013 | 259 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 789 | 0.030 |
Why?
|
| Dextrorphan | 1 | 1991 | 4 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 791 | 0.030 |
Why?
|
| Medical Informatics Applications | 1 | 1994 | 186 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12261 | 0.030 |
Why?
|
| Nimodipine | 1 | 1991 | 55 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 2012 | 206 | 0.030 |
Why?
|
| Polyvinyls | 1 | 2013 | 157 | 0.030 |
Why?
|
| E-Selectin | 1 | 2014 | 579 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 18111 | 0.030 |
Why?
|
| Paxillin | 1 | 2011 | 86 | 0.030 |
Why?
|
| Hyperemia | 1 | 1993 | 225 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2015 | 729 | 0.030 |
Why?
|
| Tretinoin | 1 | 2014 | 517 | 0.020 |
Why?
|
| Mathematics | 1 | 1993 | 728 | 0.020 |
Why?
|
| Rhombencephalon | 1 | 1991 | 85 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2006 | 2327 | 0.020 |
Why?
|
| Linear Models | 2 | 2006 | 5952 | 0.020 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2014 | 302 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2013 | 599 | 0.020 |
Why?
|
| Limit of Detection | 1 | 2012 | 265 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1993 | 15295 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 2013 | 378 | 0.020 |
Why?
|
| Leukotrienes | 1 | 2012 | 255 | 0.020 |
Why?
|
| Leucine | 1 | 2012 | 561 | 0.020 |
Why?
|
| Rubidium Radioisotopes | 1 | 1991 | 85 | 0.020 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2011 | 82 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 3507 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 1 | 2011 | 206 | 0.020 |
Why?
|
| Homozygote | 1 | 2015 | 1785 | 0.020 |
Why?
|
| Phlebography | 1 | 2012 | 333 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2012 | 341 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 644 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2004 | 5021 | 0.020 |
Why?
|
| Superoxides | 1 | 2011 | 387 | 0.020 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1993 | 277 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2014 | 3690 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 3846 | 0.020 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2015 | 518 | 0.020 |
Why?
|
| Spatial Behavior | 1 | 2010 | 90 | 0.020 |
Why?
|
| Glycemic Index | 1 | 2012 | 395 | 0.020 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2012 | 231 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2373 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 987 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2011 | 525 | 0.020 |
Why?
|
| DNA | 2 | 2004 | 7301 | 0.020 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2010 | 122 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2023 | 1979 | 0.020 |
Why?
|
| Age Factors | 2 | 2017 | 18370 | 0.020 |
Why?
|
| Microinjections | 1 | 2010 | 327 | 0.020 |
Why?
|
| Mesencephalon | 1 | 1991 | 329 | 0.020 |
Why?
|
| Nitric Oxide Donors | 1 | 2009 | 121 | 0.020 |
Why?
|
| Glycosylation | 1 | 2013 | 1126 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 713 | 0.020 |
Why?
|
| Adolescent | 6 | 2020 | 85781 | 0.020 |
Why?
|
| Microscopy | 1 | 2014 | 903 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2017 | 5535 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 1246 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 2716 | 0.020 |
Why?
|
| Phenanthridines | 1 | 2009 | 51 | 0.020 |
Why?
|
| Regression Analysis | 2 | 1996 | 6459 | 0.020 |
Why?
|
| Motor Cortex | 2 | 2007 | 986 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2009 | 180 | 0.020 |
Why?
|
| Probability | 1 | 2014 | 2505 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 976 | 0.020 |
Why?
|
| Space Perception | 1 | 2012 | 475 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2886 | 0.020 |
Why?
|
| Hemostasis | 1 | 2011 | 458 | 0.020 |
Why?
|
| Sulfones | 1 | 2011 | 437 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1736 | 0.020 |
Why?
|
| Heterozygote | 1 | 2015 | 2804 | 0.020 |
Why?
|
| Colon | 1 | 2017 | 1772 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 39050 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 2002 | 0.020 |
Why?
|
| PubMed | 1 | 2009 | 123 | 0.020 |
Why?
|
| Fibrin | 1 | 2011 | 506 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2014 | 942 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 2031 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 443 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 354 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 944 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 552 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2010 | 438 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 2645 | 0.020 |
Why?
|
| Quinolones | 1 | 2011 | 367 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 1996 | 1901 | 0.020 |
Why?
|
| Autoradiography | 1 | 2008 | 745 | 0.020 |
Why?
|
| Technology | 1 | 2010 | 305 | 0.020 |
Why?
|
| Oxyhemoglobins | 1 | 2008 | 216 | 0.020 |
Why?
|
| Sleep | 1 | 2023 | 4623 | 0.020 |
Why?
|
| Tyrosine | 1 | 2012 | 1461 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 1285 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2020 | 4217 | 0.020 |
Why?
|
| Survival Rate | 1 | 2002 | 12788 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2011 | 591 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 2008 | 577 | 0.020 |
Why?
|
| Echocardiography | 1 | 2020 | 5102 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2014 | 12208 | 0.020 |
Why?
|
| alpha-Tocopherol | 1 | 2007 | 127 | 0.020 |
Why?
|
| Tea | 1 | 2009 | 275 | 0.020 |
Why?
|
| Health Care Sector | 1 | 2009 | 194 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2008 | 356 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 453 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2015 | 1058 | 0.020 |
Why?
|
| Culture Media | 1 | 2009 | 908 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 1613 | 0.020 |
Why?
|
| Sirolimus | 1 | 2014 | 1564 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 1782 | 0.020 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2010 | 290 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2007 | 253 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2007 | 172 | 0.020 |
Why?
|
| Convalescence | 1 | 2006 | 105 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 1114 | 0.020 |
Why?
|
| Gadolinium | 1 | 1991 | 952 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 536 | 0.020 |
Why?
|
| Clone Cells | 1 | 2009 | 1692 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2010 | 5456 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 4445 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 1996 | 2576 | 0.020 |
Why?
|
| Ketamine | 1 | 1991 | 500 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2011 | 899 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2019 | 77449 | 0.020 |
Why?
|
| Hospitals | 1 | 2019 | 3952 | 0.020 |
Why?
|
| Phenols | 1 | 2009 | 497 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2012 | 1184 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2010 | 8324 | 0.020 |
Why?
|
| Luciferases | 1 | 2006 | 733 | 0.020 |
Why?
|
| Ascorbic Acid | 1 | 2007 | 651 | 0.020 |
Why?
|
| SOS1 Protein | 1 | 2004 | 41 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2009 | 852 | 0.010 |
Why?
|
| Genotype | 2 | 2010 | 12951 | 0.010 |
Why?
|
| Antibodies, Neutralizing | 1 | 2013 | 1978 | 0.010 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 1392 | 0.010 |
Why?
|
| Health Education | 1 | 2010 | 1056 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3864 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4204 | 0.010 |
Why?
|
| Heptanoic Acids | 1 | 2005 | 343 | 0.010 |
Why?
|
| Incidence | 1 | 2001 | 20947 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 2002 | 156 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3200 | 0.010 |
Why?
|
| Liver | 2 | 2012 | 7474 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2014 | 3589 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9146 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2006 | 1588 | 0.010 |
Why?
|
| Arabidopsis Proteins | 1 | 2004 | 262 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2002 | 145 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 3479 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2016 | 5102 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 8642 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2002 | 8863 | 0.010 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2002 | 227 | 0.010 |
Why?
|
| H-Reflex | 1 | 2000 | 26 | 0.010 |
Why?
|
| Analgesics | 1 | 2008 | 1040 | 0.010 |
Why?
|
| Atrophy | 1 | 2005 | 1583 | 0.010 |
Why?
|
| Dengue | 1 | 1984 | 256 | 0.010 |
Why?
|
| Eicosanoids | 1 | 2002 | 279 | 0.010 |
Why?
|
| Base Sequence | 2 | 2004 | 12797 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2010 | 1859 | 0.010 |
Why?
|
| Radial Nerve | 1 | 2000 | 43 | 0.010 |
Why?
|
| Peroneal Nerve | 1 | 2000 | 74 | 0.010 |
Why?
|
| Heart Rate | 1 | 1991 | 4091 | 0.010 |
Why?
|
| Differential Threshold | 1 | 2000 | 80 | 0.010 |
Why?
|
| Growth Substances | 1 | 2002 | 784 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2000 | 126 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 1999 | 93 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2480 | 0.010 |
Why?
|
| School Dentistry | 1 | 1999 | 5 | 0.010 |
Why?
|
| Glass Ionomer Cements | 1 | 1999 | 17 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2728 | 0.010 |
Why?
|
| Suburban Population | 1 | 1999 | 55 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2012 | 5985 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3079 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1999 | 402 | 0.010 |
Why?
|
| Wrist | 1 | 2000 | 224 | 0.010 |
Why?
|
| Pyrroles | 1 | 2005 | 1146 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 1999 | 464 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 13695 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2012 | 6256 | 0.010 |
Why?
|
| Internet | 1 | 2010 | 3064 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2001 | 2085 | 0.010 |
Why?
|
| Health Policy | 1 | 2010 | 2661 | 0.010 |
Why?
|
| Hindlimb | 1 | 1999 | 504 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.010 |
Why?
|
| Public Health | 1 | 2010 | 2603 | 0.010 |
Why?
|
| Drug Carriers | 1 | 2001 | 693 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 1999 | 936 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1999 | 506 | 0.010 |
Why?
|
| Kidney | 1 | 2012 | 7186 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 6993 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 1074 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 12959 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4560 | 0.010 |
Why?
|
| Nociceptors | 1 | 1999 | 432 | 0.010 |
Why?
|
| Feedback | 1 | 1999 | 795 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 1984 | 1772 | 0.010 |
Why?
|
| Expert Systems | 1 | 1994 | 81 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6314 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2002 | 1419 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1996 | 576 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1999 | 3128 | 0.010 |
Why?
|
| Motor Skills | 1 | 1996 | 522 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7279 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6386 | 0.010 |
Why?
|
| Child | 3 | 2015 | 77709 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1996 | 780 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1995 | 1799 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1996 | 1312 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2001 | 2214 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 4803 | 0.000 |
Why?
|
| Publishing | 1 | 1994 | 833 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4931 | 0.000 |
Why?
|
| Forecasting | 1 | 1994 | 2951 | 0.000 |
Why?
|
| Malaysia | 1 | 1984 | 92 | 0.000 |
Why?
|
| Serotyping | 1 | 1984 | 338 | 0.000 |
Why?
|
| Dengue Virus | 1 | 1984 | 204 | 0.000 |
Why?
|
| Artificial Intelligence | 1 | 1994 | 2214 | 0.000 |
Why?
|
| Seasons | 1 | 1984 | 1493 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1984 | 25625 | 0.000 |
Why?
|
| Infant | 1 | 1984 | 35136 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1984 | 41006 | 0.000 |
Why?
|